title: Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production.
abstract: Active sperm production was observed in 20 of 35 patients with testicular cancer 1 year after discontinuation of all treatment (retroperitoneal surgery only: 13; cis-platin-based chemotherapy (CVB) +/- other treatment: 22). The percentage of patients who regained spermatogenesis increased slightly after a further 1 to 2 years. Fourteen patients (of 121 under observation) impregnated their wives (after retroperitoneal surgery: 9; after CVB +/- other therapy: 5). The individual serum FSH values correlated significantly with the results of sperm analysis: an FSH value greater than or equal to 20 iu/l indicated azoospermia in 8 of 12 patients, whereas only 5 of 30 patients with FSH levels less than or equal to 12 iu/l were azoospermic. Serum testosterone and pituitary serum LH were virtually unaffected by the treatment. In conclusion, 1 to 3 years after cis-platin-based multi-modality treatment for testicular cancer, 50 to 60% of patients have active spermatogenesis and fatherhood can be achieved by a significant number of them.
authors.forename: S D
authors.initials: SD
authors.lastname: Fosså
authors.forename: S
authors.initials: S
authors.lastname: Ous
authors.forename: T
authors.initials: T
authors.lastname: Abyholm
authors.forename: N
authors.initials: N
authors.lastname: Norman
authors.forename: M
authors.initials: M
authors.lastname: Loeb
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D007248:Infertility, Male / Q000209:etiology; D008197:Lymph Node Excision / Q000009:adverse effects*; D008297:Male; D012187:Retroperitoneal Space; D013091:Spermatogenesis / Q000187:drug effects; D013736:Testicular Neoplasms / Q000628:therapy*; D013739:Testosterone / Q000097:blood; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014751:Vindesine
chemical_list: D006065:Gonadotropins, Pituitary; D001761:Bleomycin; D013739:Testosterone; D014747:Vinblastine; D002945:Cisplatin; D014751:Vindesine